Abstract & Article Details
Short Communication • Vol.5, Issue 9 • ISSN: 2766-2276 • Open Access • CC BY 4.0
Prophylaxis by Administration of Stable Iodine: Principle, Evolution and Recommendations
Abstract
Prophylaxis by stable iodine “KI 65 mg, breakable tablet†is a pharmacological countermeasure of radiological protection adapted for the prevention of thyroid cancer after exposure to radioactive iodine. A first modification of the marketing authorization of “KI 65 mg, breakable tablet†for repeated prophylaxis for adults and children above 12 years old was obtained in France in 2020. At this point in time, the recommendation of a unique “KI†intake by pregnant and breastfeeding women and children below 12 years old remain valid.
Research Topics
How to Cite
Article Information
| Journal | Journal of Biomedical Research & Environmental Sciences (JBRES) |
|---|---|
| ISSN | 2766-2276 |
| DOI | DOI 10.37871/jbres1996 |
| Volume / Issue | Vol. 5, Issue 9 |
| Received | September 3, 2024 |
| Accepted | September 8, 2024 |
| Published | September 11, 2024 |
| Article Type | Short Communication |
| Pages | 1109-1110 |
| License | CC BY 4.0 — Open Access |
| Publisher | SciRes Literature LLC, Sheridan, WY, USA |
| Language | English |
Published under CC BY 4.0 — free to share, copy, adapt, and redistribute with attribution.
Certificate of Publication
Certificate verifies that this article was peer-reviewed and published in the Journal of Biomedical Research & Environmental Sciences.